| Serial Number | 88402237 |
| Word Mark | TRANSFORMATIONAL MEDICINES THAT MAKE A DIFFERENCE |
| Filing Date | Thursday, April 25, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, June 5, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 10, 2020 |
| Goods and Services | Pharmaceuticals, namely, medical and veterinary pharmaceutical preparations for the treatment of human and animal diseases of the respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; sanitary preparations for medical purposes; dietetic food adapted for medical or veterinary use; diagnostic preparations and materials, namely, diagnostic agents, preparations and substances for medical, pharmaceutical and veterinary purposes; disinfectants and antiseptics; medical dressings, coverings and applicators, namely, bandages for dressings, gauze for dressings, dressings for wounds, burns and surgery, cotton and synthetic swabs for medical use, adhesive plasters for medical use, inhalers filled with pharmaceutical products for the treatment of respiratory diseases and disorders; natural remedies, namely, natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances and sleep disorders, and for the treatment of human diseases and disorders of the respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; natural dietary supplements for the treatment of human diseases and disorders of the respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; pharmaceutical products for treatment of human diseases of the respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; pharmaceutical preparations for the treatment of cancer and pain; pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations and substances for the treatment of ocular and dermatological diseases and disorders; pharmaceutical preparations and substances for the treatment of bacterial and viral infections, namely, anti-infectives |
| Goods and Services | Scientific and technological services, namely, scientific research, analysis, design and testing, in the field of pharmaceuticals and medicine; medical and pharmacological research services in the field of pharmaceuticals and medicine; natural science services, namely, scientific research, analysis, design and testing in the field of natural medicine and natural remedies; testing, namely, testing of pharmaceuticals and providing medical testing services in the field of research into human diseases of the respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; authentication, namely, authentication of pharmaceutical and medicines; quality control for others; scientific investigation for medical purposes; bacteriological, chemical and biological investigation being scientific investigation for medical purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, May 11, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, May 11, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Theravance Biopharma R&D IP, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | South San Francisco, CA 94080 |
| Party Name | Theravance Biopharma R&D IP, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | South San Francisco, CA 94080 |
| Event Date | Event Description |
| Monday, June 5, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, June 5, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, November 11, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 10, 2022 | SOU EXTENSION 5 GRANTED |
| Thursday, November 3, 2022 | SOU EXTENSION 5 FILED |
| Thursday, November 10, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, November 3, 2022 | TEAS EXTENSION RECEIVED |
| Saturday, April 30, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, April 28, 2022 | SOU EXTENSION 4 GRANTED |
| Thursday, April 28, 2022 | SOU EXTENSION 4 FILED |
| Thursday, April 28, 2022 | TEAS EXTENSION RECEIVED |
| Saturday, October 9, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 7, 2021 | SOU EXTENSION 3 GRANTED |
| Thursday, October 7, 2021 | SOU EXTENSION 3 FILED |
| Thursday, October 7, 2021 | TEAS EXTENSION RECEIVED |
| Saturday, May 1, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, April 29, 2021 | SOU EXTENSION 2 GRANTED |
| Thursday, April 29, 2021 | SOU EXTENSION 2 FILED |
| Thursday, April 29, 2021 | TEAS EXTENSION RECEIVED |
| Wednesday, September 23, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, September 21, 2020 | SOU EXTENSION 1 GRANTED |
| Monday, September 21, 2020 | SOU EXTENSION 1 FILED |
| Monday, September 21, 2020 | TEAS EXTENSION RECEIVED |
| Tuesday, May 5, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 10, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 10, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 19, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, February 3, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, February 3, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Monday, February 3, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, February 3, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Monday, February 3, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, January 13, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, January 11, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, January 11, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 22, 2019 | NON-FINAL ACTION MAILED |
| Wednesday, July 10, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, July 8, 2019 | ASSIGNED TO EXAMINER |
| Saturday, May 11, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 29, 2019 | NEW APPLICATION ENTERED |